Global Endocrine Testing System

Endocrine Testing System Comprehensive Study by Type (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (HCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Others), Application (Hospitals, Commercial Laboratories, Ambulatory Care Centers, Home-based tests, Other settings), Technology (Liquid Chromatography-Mass Spectrometry (LC-MS), ELISA, Tandem Mass Spectrometry, Immunoassay, Others) Players and Region - Global Market Outlook to 2027

Endocrine Testing System Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Endocrine Testing System Market Scope?
The system includes the endocrine glands like the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the body’s metabolism, growth, sexual development, and performance. Endocrine tests facilitate assessing the traditional functioning of the secretor by checking the internal secretion levels. The tests find an imbalance in secretion levels. The endocrine testing market is driven by the increasing incidences of endocrine disorders like polygenic disorder, thyroid disorders, physiological conditions, etc. This has conjointly resulted in the development of recent technologies, which is driving the expansion of this market. High development prices needed for developing new technologies might impede the expansion of this market. The opportunities for this market are tremendous as rising incidences of endocrine disorders and increasing health care awareness would need speedy, sensitive, and affordable tests.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledAgilent Technologies (United States), Abbott Laboratories (United States), Biomedical Diagnostics (United States), Bio-Rad Laboratories Inc. (United States), F.Hoffman-La Roche Ltd (Switzerland), ImmunoDX (United States), Laboratory Corporation (United States), Nano EnTek (South Korea), Siemens AG (Germany) and Thermo Fisher Scientific Inc. (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Endocrine Testing System market study is being classified by Type (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (HCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test and Others), by Application (Hospitals, Commercial Laboratories, Ambulatory Care Centers, Home-based tests and Other settings) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Endocrine Testing System market throughout the predicted period.

Agilent Technologies (United States), Abbott Laboratories (United States), Biomedical Diagnostics (United States), Bio-Rad Laboratories Inc. (United States), F.Hoffman-La Roche Ltd (Switzerland), ImmunoDX (United States), Laboratory Corporation (United States), Nano EnTek (South Korea), Siemens AG (Germany) and Thermo Fisher Scientific Inc. (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Endocrine Testing System market by Type, Application and Region.

On the basis of geography, the market of Endocrine Testing System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In July 2020, Renalytix AI and Mount Sinai Health System collaborated to study COVID-19 patients and their risk of acute and chronic kidney disease. The study, Prediction of Major Adverse Kidney Events and Recovery (Pred-MAKER), will use the KidneyIntelX to analyze plasma and urine biomarkers in admitted patients.
In May 2020, Roche acquired Stratos Genomics to further develop DNA-based sequencing for diagnostic use of endocrine diagnostics., In March 2020, Thermo Fisher Scientific proposed to acquire QIAGEN N.V. as this acquisition would expand its specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing like the endocrine diagnosis. and In July 2019, Thermo Fisher Scientific announced a 3-year, collaboration with the Ontario Institute for Cancer Research (OICR) and Genome Canada to develop targeted next-generation sequencing-based assays and analysis software to test the cases of diseases.
The development of new endocrine disruption-relevant test methods has been the subject of intensive research efforts for the past several decades, prompted in part by mandates in the 1996 Food Quality Protection Act (FQPA).

Influencing Market Trend
  • Increasing Trend of Adoption of The Diagnosis Techniques

Market Drivers
  • The Surge in Number of People with Endocrine and Metabolic Disorders
  • The Prevalence of Diabetes and PCOS Have Increased
  • Constant Rise in The Geriatric Population

Opportunities
  • The Key Players Are Investing in Research and Development
  • Increasing Efforts from The Government to Spread Awareness About Various Programs

Restraints
  • High Cost of The Technology

Challenges
  • Lack of Healthcare Infrastructure
  • Lack of Skilled Personnel


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Endocrine Testing System, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (HCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Others
By Application
  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Home-based tests
  • Other settings
By Technology
  • Liquid Chromatography-Mass Spectrometry (LC-MS)
  • ELISA
  • Tandem Mass Spectrometry
  • Immunoassay
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Surge in Number of People with Endocrine and Metabolic Disorders
      • 3.2.2. The Prevalence of Diabetes and PCOS Have Increased
      • 3.2.3. Constant Rise in The Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Healthcare Infrastructure
      • 3.3.2. Lack of Skilled Personnel
    • 3.4. Market Trends
      • 3.4.1. Increasing Trend of Adoption of The Diagnosis Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Endocrine Testing System, by Type, Application, Technology and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Endocrine Testing System (Value)
      • 5.2.1. Global Endocrine Testing System by: Type (Value)
        • 5.2.1.1. Estradiol (E2) Test
        • 5.2.1.2. Follicle Stimulating Hormone (FSH) Test
        • 5.2.1.3. Human Chorionic Gonadotropin (HCG) Hormone Test
        • 5.2.1.4. Luteinizing Hormone (LH) Test
        • 5.2.1.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
        • 5.2.1.6. Progesterone Test
        • 5.2.1.7. Others
      • 5.2.2. Global Endocrine Testing System by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Commercial Laboratories
        • 5.2.2.3. Ambulatory Care Centers
        • 5.2.2.4. Home-based tests
        • 5.2.2.5. Other settings
      • 5.2.3. Global Endocrine Testing System by: Technology (Value)
        • 5.2.3.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
        • 5.2.3.2. ELISA
        • 5.2.3.3. Tandem Mass Spectrometry
        • 5.2.3.4. Immunoassay
        • 5.2.3.5. Others
      • 5.2.4. Global Endocrine Testing System Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Endocrine Testing System (Volume)
      • 5.3.1. Global Endocrine Testing System by: Type (Volume)
        • 5.3.1.1. Estradiol (E2) Test
        • 5.3.1.2. Follicle Stimulating Hormone (FSH) Test
        • 5.3.1.3. Human Chorionic Gonadotropin (HCG) Hormone Test
        • 5.3.1.4. Luteinizing Hormone (LH) Test
        • 5.3.1.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
        • 5.3.1.6. Progesterone Test
        • 5.3.1.7. Others
      • 5.3.2. Global Endocrine Testing System by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Commercial Laboratories
        • 5.3.2.3. Ambulatory Care Centers
        • 5.3.2.4. Home-based tests
        • 5.3.2.5. Other settings
      • 5.3.3. Global Endocrine Testing System by: Technology (Volume)
        • 5.3.3.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
        • 5.3.3.2. ELISA
        • 5.3.3.3. Tandem Mass Spectrometry
        • 5.3.3.4. Immunoassay
        • 5.3.3.5. Others
      • 5.3.4. Global Endocrine Testing System Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Endocrine Testing System (Price)
      • 5.4.1. Global Endocrine Testing System by: Type (Price)
  • 6. Endocrine Testing System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biomedical Diagnostics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bio-Rad Laboratories Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. F.Hoffman-La Roche Ltd (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ImmunoDX (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Laboratory Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nano EnTek (South Korea)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Siemens AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Endocrine Testing System Sale, by Type, Application, Technology and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Endocrine Testing System (Value)
      • 7.2.1. Global Endocrine Testing System by: Type (Value)
        • 7.2.1.1. Estradiol (E2) Test
        • 7.2.1.2. Follicle Stimulating Hormone (FSH) Test
        • 7.2.1.3. Human Chorionic Gonadotropin (HCG) Hormone Test
        • 7.2.1.4. Luteinizing Hormone (LH) Test
        • 7.2.1.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
        • 7.2.1.6. Progesterone Test
        • 7.2.1.7. Others
      • 7.2.2. Global Endocrine Testing System by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Commercial Laboratories
        • 7.2.2.3. Ambulatory Care Centers
        • 7.2.2.4. Home-based tests
        • 7.2.2.5. Other settings
      • 7.2.3. Global Endocrine Testing System by: Technology (Value)
        • 7.2.3.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
        • 7.2.3.2. ELISA
        • 7.2.3.3. Tandem Mass Spectrometry
        • 7.2.3.4. Immunoassay
        • 7.2.3.5. Others
      • 7.2.4. Global Endocrine Testing System Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Endocrine Testing System (Volume)
      • 7.3.1. Global Endocrine Testing System by: Type (Volume)
        • 7.3.1.1. Estradiol (E2) Test
        • 7.3.1.2. Follicle Stimulating Hormone (FSH) Test
        • 7.3.1.3. Human Chorionic Gonadotropin (HCG) Hormone Test
        • 7.3.1.4. Luteinizing Hormone (LH) Test
        • 7.3.1.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
        • 7.3.1.6. Progesterone Test
        • 7.3.1.7. Others
      • 7.3.2. Global Endocrine Testing System by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Commercial Laboratories
        • 7.3.2.3. Ambulatory Care Centers
        • 7.3.2.4. Home-based tests
        • 7.3.2.5. Other settings
      • 7.3.3. Global Endocrine Testing System by: Technology (Volume)
        • 7.3.3.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
        • 7.3.3.2. ELISA
        • 7.3.3.3. Tandem Mass Spectrometry
        • 7.3.3.4. Immunoassay
        • 7.3.3.5. Others
      • 7.3.4. Global Endocrine Testing System Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Endocrine Testing System (Price)
      • 7.4.1. Global Endocrine Testing System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Endocrine Testing System: by Type(USD Million)
  • Table 2. Endocrine Testing System Estradiol (E2) Test , by Region USD Million (2016-2021)
  • Table 3. Endocrine Testing System Follicle Stimulating Hormone (FSH) Test , by Region USD Million (2016-2021)
  • Table 4. Endocrine Testing System Human Chorionic Gonadotropin (HCG) Hormone Test , by Region USD Million (2016-2021)
  • Table 5. Endocrine Testing System Luteinizing Hormone (LH) Test , by Region USD Million (2016-2021)
  • Table 6. Endocrine Testing System Dehydroepiandrosterone Sulfate (DHEAS) Test , by Region USD Million (2016-2021)
  • Table 7. Endocrine Testing System Progesterone Test , by Region USD Million (2016-2021)
  • Table 8. Endocrine Testing System Others , by Region USD Million (2016-2021)
  • Table 9. Endocrine Testing System: by Application(USD Million)
  • Table 10. Endocrine Testing System Hospitals , by Region USD Million (2016-2021)
  • Table 11. Endocrine Testing System Commercial Laboratories , by Region USD Million (2016-2021)
  • Table 12. Endocrine Testing System Ambulatory Care Centers , by Region USD Million (2016-2021)
  • Table 13. Endocrine Testing System Home-based tests , by Region USD Million (2016-2021)
  • Table 14. Endocrine Testing System Other settings , by Region USD Million (2016-2021)
  • Table 15. Endocrine Testing System: by Technology(USD Million)
  • Table 16. Endocrine Testing System Liquid Chromatography-Mass Spectrometry (LC-MS) , by Region USD Million (2016-2021)
  • Table 17. Endocrine Testing System ELISA , by Region USD Million (2016-2021)
  • Table 18. Endocrine Testing System Tandem Mass Spectrometry , by Region USD Million (2016-2021)
  • Table 19. Endocrine Testing System Immunoassay , by Region USD Million (2016-2021)
  • Table 20. Endocrine Testing System Others , by Region USD Million (2016-2021)
  • Table 21. South America Endocrine Testing System, by Country USD Million (2016-2021)
  • Table 22. South America Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 23. South America Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 24. South America Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 25. Brazil Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 26. Brazil Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 27. Brazil Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 28. Argentina Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 29. Argentina Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 30. Argentina Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 31. Rest of South America Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 34. Asia Pacific Endocrine Testing System, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 36. Asia Pacific Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 37. Asia Pacific Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 38. China Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 39. China Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 40. China Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 41. Japan Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 42. Japan Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 43. Japan Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 44. India Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 45. India Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 46. India Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 47. South Korea Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 48. South Korea Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 49. South Korea Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 50. Taiwan Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 51. Taiwan Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 52. Taiwan Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 53. Australia Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 54. Australia Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 55. Australia Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 57. Rest of Asia-Pacific Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 58. Rest of Asia-Pacific Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 59. Europe Endocrine Testing System, by Country USD Million (2016-2021)
  • Table 60. Europe Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 61. Europe Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 62. Europe Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 63. Germany Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 64. Germany Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 65. Germany Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 66. France Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 67. France Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 68. France Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 69. Italy Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 70. Italy Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 71. Italy Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 72. United Kingdom Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 73. United Kingdom Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 74. United Kingdom Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 75. Netherlands Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 76. Netherlands Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 77. Netherlands Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 78. Rest of Europe Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 79. Rest of Europe Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 80. Rest of Europe Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 81. MEA Endocrine Testing System, by Country USD Million (2016-2021)
  • Table 82. MEA Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 83. MEA Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 84. MEA Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 85. Middle East Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 86. Middle East Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 87. Middle East Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 88. Africa Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 89. Africa Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 90. Africa Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 91. North America Endocrine Testing System, by Country USD Million (2016-2021)
  • Table 92. North America Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 93. North America Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 94. North America Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 95. United States Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 96. United States Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 97. United States Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 98. Canada Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 99. Canada Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 100. Canada Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 101. Mexico Endocrine Testing System, by Type USD Million (2016-2021)
  • Table 102. Mexico Endocrine Testing System, by Application USD Million (2016-2021)
  • Table 103. Mexico Endocrine Testing System, by Technology USD Million (2016-2021)
  • Table 104. Endocrine Testing System Sales: by Type(K Units)
  • Table 105. Endocrine Testing System Sales Estradiol (E2) Test , by Region K Units (2016-2021)
  • Table 106. Endocrine Testing System Sales Follicle Stimulating Hormone (FSH) Test , by Region K Units (2016-2021)
  • Table 107. Endocrine Testing System Sales Human Chorionic Gonadotropin (HCG) Hormone Test , by Region K Units (2016-2021)
  • Table 108. Endocrine Testing System Sales Luteinizing Hormone (LH) Test , by Region K Units (2016-2021)
  • Table 109. Endocrine Testing System Sales Dehydroepiandrosterone Sulfate (DHEAS) Test , by Region K Units (2016-2021)
  • Table 110. Endocrine Testing System Sales Progesterone Test , by Region K Units (2016-2021)
  • Table 111. Endocrine Testing System Sales Others , by Region K Units (2016-2021)
  • Table 112. Endocrine Testing System Sales: by Application(K Units)
  • Table 113. Endocrine Testing System Sales Hospitals , by Region K Units (2016-2021)
  • Table 114. Endocrine Testing System Sales Commercial Laboratories , by Region K Units (2016-2021)
  • Table 115. Endocrine Testing System Sales Ambulatory Care Centers , by Region K Units (2016-2021)
  • Table 116. Endocrine Testing System Sales Home-based tests , by Region K Units (2016-2021)
  • Table 117. Endocrine Testing System Sales Other settings , by Region K Units (2016-2021)
  • Table 118. Endocrine Testing System Sales: by Technology(K Units)
  • Table 119. Endocrine Testing System Sales Liquid Chromatography-Mass Spectrometry (LC-MS) , by Region K Units (2016-2021)
  • Table 120. Endocrine Testing System Sales ELISA , by Region K Units (2016-2021)
  • Table 121. Endocrine Testing System Sales Tandem Mass Spectrometry , by Region K Units (2016-2021)
  • Table 122. Endocrine Testing System Sales Immunoassay , by Region K Units (2016-2021)
  • Table 123. Endocrine Testing System Sales Others , by Region K Units (2016-2021)
  • Table 124. South America Endocrine Testing System Sales, by Country K Units (2016-2021)
  • Table 125. South America Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 126. South America Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 127. South America Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 128. Brazil Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 129. Brazil Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 130. Brazil Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 131. Argentina Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 132. Argentina Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 133. Argentina Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 134. Rest of South America Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 135. Rest of South America Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 136. Rest of South America Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 137. Asia Pacific Endocrine Testing System Sales, by Country K Units (2016-2021)
  • Table 138. Asia Pacific Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 139. Asia Pacific Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 140. Asia Pacific Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 141. China Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 142. China Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 143. China Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 144. Japan Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 145. Japan Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 146. Japan Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 147. India Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 148. India Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 149. India Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 150. South Korea Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 151. South Korea Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 152. South Korea Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 153. Taiwan Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 154. Taiwan Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 155. Taiwan Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 156. Australia Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 157. Australia Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 158. Australia Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 159. Rest of Asia-Pacific Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 160. Rest of Asia-Pacific Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 161. Rest of Asia-Pacific Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 162. Europe Endocrine Testing System Sales, by Country K Units (2016-2021)
  • Table 163. Europe Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 164. Europe Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 165. Europe Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 166. Germany Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 167. Germany Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 168. Germany Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 169. France Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 170. France Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 171. France Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 172. Italy Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 173. Italy Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 174. Italy Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 175. United Kingdom Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 176. United Kingdom Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 177. United Kingdom Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 178. Netherlands Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 179. Netherlands Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 180. Netherlands Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 181. Rest of Europe Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 182. Rest of Europe Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 183. Rest of Europe Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 184. MEA Endocrine Testing System Sales, by Country K Units (2016-2021)
  • Table 185. MEA Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 186. MEA Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 187. MEA Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 188. Middle East Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 189. Middle East Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 190. Middle East Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 191. Africa Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 192. Africa Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 193. Africa Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 194. North America Endocrine Testing System Sales, by Country K Units (2016-2021)
  • Table 195. North America Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 196. North America Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 197. North America Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 198. United States Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 199. United States Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 200. United States Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 201. Canada Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 202. Canada Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 203. Canada Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 204. Mexico Endocrine Testing System Sales, by Type K Units (2016-2021)
  • Table 205. Mexico Endocrine Testing System Sales, by Application K Units (2016-2021)
  • Table 206. Mexico Endocrine Testing System Sales, by Technology K Units (2016-2021)
  • Table 207. Endocrine Testing System: by Type(USD/Units)
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Endocrine Testing System: by Type(USD Million)
  • Table 219. Endocrine Testing System Estradiol (E2) Test , by Region USD Million (2022-2027)
  • Table 220. Endocrine Testing System Follicle Stimulating Hormone (FSH) Test , by Region USD Million (2022-2027)
  • Table 221. Endocrine Testing System Human Chorionic Gonadotropin (HCG) Hormone Test , by Region USD Million (2022-2027)
  • Table 222. Endocrine Testing System Luteinizing Hormone (LH) Test , by Region USD Million (2022-2027)
  • Table 223. Endocrine Testing System Dehydroepiandrosterone Sulfate (DHEAS) Test , by Region USD Million (2022-2027)
  • Table 224. Endocrine Testing System Progesterone Test , by Region USD Million (2022-2027)
  • Table 225. Endocrine Testing System Others , by Region USD Million (2022-2027)
  • Table 226. Endocrine Testing System: by Application(USD Million)
  • Table 227. Endocrine Testing System Hospitals , by Region USD Million (2022-2027)
  • Table 228. Endocrine Testing System Commercial Laboratories , by Region USD Million (2022-2027)
  • Table 229. Endocrine Testing System Ambulatory Care Centers , by Region USD Million (2022-2027)
  • Table 230. Endocrine Testing System Home-based tests , by Region USD Million (2022-2027)
  • Table 231. Endocrine Testing System Other settings , by Region USD Million (2022-2027)
  • Table 232. Endocrine Testing System: by Technology(USD Million)
  • Table 233. Endocrine Testing System Liquid Chromatography-Mass Spectrometry (LC-MS) , by Region USD Million (2022-2027)
  • Table 234. Endocrine Testing System ELISA , by Region USD Million (2022-2027)
  • Table 235. Endocrine Testing System Tandem Mass Spectrometry , by Region USD Million (2022-2027)
  • Table 236. Endocrine Testing System Immunoassay , by Region USD Million (2022-2027)
  • Table 237. Endocrine Testing System Others , by Region USD Million (2022-2027)
  • Table 238. South America Endocrine Testing System, by Country USD Million (2022-2027)
  • Table 239. South America Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 240. South America Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 241. South America Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 242. Brazil Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 243. Brazil Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 244. Brazil Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 245. Argentina Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 246. Argentina Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 247. Argentina Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 248. Rest of South America Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 249. Rest of South America Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 250. Rest of South America Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 251. Asia Pacific Endocrine Testing System, by Country USD Million (2022-2027)
  • Table 252. Asia Pacific Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 253. Asia Pacific Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 254. Asia Pacific Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 255. China Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 256. China Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 257. China Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 258. Japan Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 259. Japan Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 260. Japan Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 261. India Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 262. India Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 263. India Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 264. South Korea Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 265. South Korea Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 266. South Korea Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 267. Taiwan Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 268. Taiwan Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 269. Taiwan Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 270. Australia Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 271. Australia Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 272. Australia Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 273. Rest of Asia-Pacific Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 274. Rest of Asia-Pacific Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 275. Rest of Asia-Pacific Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 276. Europe Endocrine Testing System, by Country USD Million (2022-2027)
  • Table 277. Europe Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 278. Europe Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 279. Europe Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 280. Germany Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 281. Germany Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 282. Germany Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 283. France Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 284. France Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 285. France Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 286. Italy Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 287. Italy Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 288. Italy Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 289. United Kingdom Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 290. United Kingdom Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 291. United Kingdom Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 292. Netherlands Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 293. Netherlands Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 294. Netherlands Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 295. Rest of Europe Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 296. Rest of Europe Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 297. Rest of Europe Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 298. MEA Endocrine Testing System, by Country USD Million (2022-2027)
  • Table 299. MEA Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 300. MEA Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 301. MEA Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 302. Middle East Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 303. Middle East Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 304. Middle East Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 305. Africa Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 306. Africa Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 307. Africa Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 308. North America Endocrine Testing System, by Country USD Million (2022-2027)
  • Table 309. North America Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 310. North America Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 311. North America Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 312. United States Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 313. United States Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 314. United States Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 315. Canada Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 316. Canada Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 317. Canada Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 318. Mexico Endocrine Testing System, by Type USD Million (2022-2027)
  • Table 319. Mexico Endocrine Testing System, by Application USD Million (2022-2027)
  • Table 320. Mexico Endocrine Testing System, by Technology USD Million (2022-2027)
  • Table 321. Endocrine Testing System Sales: by Type(K Units)
  • Table 322. Endocrine Testing System Sales Estradiol (E2) Test , by Region K Units (2022-2027)
  • Table 323. Endocrine Testing System Sales Follicle Stimulating Hormone (FSH) Test , by Region K Units (2022-2027)
  • Table 324. Endocrine Testing System Sales Human Chorionic Gonadotropin (HCG) Hormone Test , by Region K Units (2022-2027)
  • Table 325. Endocrine Testing System Sales Luteinizing Hormone (LH) Test , by Region K Units (2022-2027)
  • Table 326. Endocrine Testing System Sales Dehydroepiandrosterone Sulfate (DHEAS) Test , by Region K Units (2022-2027)
  • Table 327. Endocrine Testing System Sales Progesterone Test , by Region K Units (2022-2027)
  • Table 328. Endocrine Testing System Sales Others , by Region K Units (2022-2027)
  • Table 329. Endocrine Testing System Sales: by Application(K Units)
  • Table 330. Endocrine Testing System Sales Hospitals , by Region K Units (2022-2027)
  • Table 331. Endocrine Testing System Sales Commercial Laboratories , by Region K Units (2022-2027)
  • Table 332. Endocrine Testing System Sales Ambulatory Care Centers , by Region K Units (2022-2027)
  • Table 333. Endocrine Testing System Sales Home-based tests , by Region K Units (2022-2027)
  • Table 334. Endocrine Testing System Sales Other settings , by Region K Units (2022-2027)
  • Table 335. Endocrine Testing System Sales: by Technology(K Units)
  • Table 336. Endocrine Testing System Sales Liquid Chromatography-Mass Spectrometry (LC-MS) , by Region K Units (2022-2027)
  • Table 337. Endocrine Testing System Sales ELISA , by Region K Units (2022-2027)
  • Table 338. Endocrine Testing System Sales Tandem Mass Spectrometry , by Region K Units (2022-2027)
  • Table 339. Endocrine Testing System Sales Immunoassay , by Region K Units (2022-2027)
  • Table 340. Endocrine Testing System Sales Others , by Region K Units (2022-2027)
  • Table 341. South America Endocrine Testing System Sales, by Country K Units (2022-2027)
  • Table 342. South America Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 343. South America Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 344. South America Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 345. Brazil Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 346. Brazil Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 347. Brazil Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 348. Argentina Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 349. Argentina Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 350. Argentina Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 351. Rest of South America Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 352. Rest of South America Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 353. Rest of South America Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 354. Asia Pacific Endocrine Testing System Sales, by Country K Units (2022-2027)
  • Table 355. Asia Pacific Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 356. Asia Pacific Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 357. Asia Pacific Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 358. China Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 359. China Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 360. China Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 361. Japan Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 362. Japan Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 363. Japan Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 364. India Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 365. India Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 366. India Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 367. South Korea Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 368. South Korea Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 369. South Korea Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 370. Taiwan Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 371. Taiwan Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 372. Taiwan Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 373. Australia Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 374. Australia Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 375. Australia Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 376. Rest of Asia-Pacific Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 377. Rest of Asia-Pacific Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 378. Rest of Asia-Pacific Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 379. Europe Endocrine Testing System Sales, by Country K Units (2022-2027)
  • Table 380. Europe Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 381. Europe Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 382. Europe Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 383. Germany Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 384. Germany Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 385. Germany Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 386. France Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 387. France Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 388. France Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 389. Italy Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 390. Italy Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 391. Italy Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 392. United Kingdom Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 393. United Kingdom Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 394. United Kingdom Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 395. Netherlands Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 396. Netherlands Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 397. Netherlands Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 398. Rest of Europe Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 399. Rest of Europe Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 400. Rest of Europe Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 401. MEA Endocrine Testing System Sales, by Country K Units (2022-2027)
  • Table 402. MEA Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 403. MEA Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 404. MEA Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 405. Middle East Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 406. Middle East Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 407. Middle East Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 408. Africa Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 409. Africa Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 410. Africa Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 411. North America Endocrine Testing System Sales, by Country K Units (2022-2027)
  • Table 412. North America Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 413. North America Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 414. North America Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 415. United States Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 416. United States Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 417. United States Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 418. Canada Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 419. Canada Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 420. Canada Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 421. Mexico Endocrine Testing System Sales, by Type K Units (2022-2027)
  • Table 422. Mexico Endocrine Testing System Sales, by Application K Units (2022-2027)
  • Table 423. Mexico Endocrine Testing System Sales, by Technology K Units (2022-2027)
  • Table 424. Endocrine Testing System: by Type(USD/Units)
  • Table 425. Research Programs/Design for This Report
  • Table 426. Key Data Information from Secondary Sources
  • Table 427. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Endocrine Testing System: by Type USD Million (2016-2021)
  • Figure 5. Global Endocrine Testing System: by Application USD Million (2016-2021)
  • Figure 6. Global Endocrine Testing System: by Technology USD Million (2016-2021)
  • Figure 7. South America Endocrine Testing System Share (%), by Country
  • Figure 8. Asia Pacific Endocrine Testing System Share (%), by Country
  • Figure 9. Europe Endocrine Testing System Share (%), by Country
  • Figure 10. MEA Endocrine Testing System Share (%), by Country
  • Figure 11. North America Endocrine Testing System Share (%), by Country
  • Figure 12. Global Endocrine Testing System: by Type K Units (2016-2021)
  • Figure 13. Global Endocrine Testing System: by Application K Units (2016-2021)
  • Figure 14. Global Endocrine Testing System: by Technology K Units (2016-2021)
  • Figure 15. South America Endocrine Testing System Share (%), by Country
  • Figure 16. Asia Pacific Endocrine Testing System Share (%), by Country
  • Figure 17. Europe Endocrine Testing System Share (%), by Country
  • Figure 18. MEA Endocrine Testing System Share (%), by Country
  • Figure 19. North America Endocrine Testing System Share (%), by Country
  • Figure 20. Global Endocrine Testing System: by Type USD/Units (2016-2021)
  • Figure 21. Global Endocrine Testing System share by Players 2021 (%)
  • Figure 22. Global Endocrine Testing System share by Players (Top 3) 2021(%)
  • Figure 23. Global Endocrine Testing System share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 26. Agilent Technologies (United States) Revenue: by Geography 2021
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 29. Biomedical Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Biomedical Diagnostics (United States) Revenue: by Geography 2021
  • Figure 31. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2021
  • Figure 33. F.Hoffman-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F.Hoffman-La Roche Ltd (Switzerland) Revenue: by Geography 2021
  • Figure 35. ImmunoDX (United States) Revenue, Net Income and Gross profit
  • Figure 36. ImmunoDX (United States) Revenue: by Geography 2021
  • Figure 37. Laboratory Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Laboratory Corporation (United States) Revenue: by Geography 2021
  • Figure 39. Nano EnTek (South Korea) Revenue, Net Income and Gross profit
  • Figure 40. Nano EnTek (South Korea) Revenue: by Geography 2021
  • Figure 41. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Siemens AG (Germany) Revenue: by Geography 2021
  • Figure 43. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 45. Global Endocrine Testing System: by Type USD Million (2022-2027)
  • Figure 46. Global Endocrine Testing System: by Application USD Million (2022-2027)
  • Figure 47. Global Endocrine Testing System: by Technology USD Million (2022-2027)
  • Figure 48. South America Endocrine Testing System Share (%), by Country
  • Figure 49. Asia Pacific Endocrine Testing System Share (%), by Country
  • Figure 50. Europe Endocrine Testing System Share (%), by Country
  • Figure 51. MEA Endocrine Testing System Share (%), by Country
  • Figure 52. North America Endocrine Testing System Share (%), by Country
  • Figure 53. Global Endocrine Testing System: by Type K Units (2022-2027)
  • Figure 54. Global Endocrine Testing System: by Application K Units (2022-2027)
  • Figure 55. Global Endocrine Testing System: by Technology K Units (2022-2027)
  • Figure 56. South America Endocrine Testing System Share (%), by Country
  • Figure 57. Asia Pacific Endocrine Testing System Share (%), by Country
  • Figure 58. Europe Endocrine Testing System Share (%), by Country
  • Figure 59. MEA Endocrine Testing System Share (%), by Country
  • Figure 60. North America Endocrine Testing System Share (%), by Country
  • Figure 61. Global Endocrine Testing System: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Agilent Technologies (United States)
  • Abbott Laboratories (United States)
  • Biomedical Diagnostics (United States)
  • Bio-Rad Laboratories Inc. (United States)
  • F.Hoffman-La Roche Ltd (Switzerland)
  • ImmunoDX (United States)
  • Laboratory Corporation (United States)
  • Nano EnTek (South Korea)
  • Siemens AG (Germany)
  • Thermo Fisher Scientific Inc. (United States)
Select User Access Type

Key Highlights of Report


May 2022 155 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Endocrine Testing System Quantitative research analysis
Global Endocrine Testing System Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Endocrine Testing System market is expected to see a growth of % during projected year 2021 to 2027.
The prominent players of Global Endocrine Testing System market are Agilent Technologies (United States), Abbott Laboratories (United States), Biomedical Diagnostics (United States), Bio-Rad Laboratories Inc. (United States), F.Hoffman-La Roche Ltd (Switzerland), ImmunoDX (United States), Laboratory Corporation (United States), Nano EnTek (South Korea), Siemens AG (Germany) and Thermo Fisher Scientific Inc. (United States), to view complete player list click here

Know More About Global Endocrine Testing System Report?

Have a Query? Click Here

Other Related Reports

Mumps Vaccine Comprehensive Study by Type (Mono Vaccines, Combination Vaccines, Others), Distribution Channel (Hospitals Pharmacies, Drug Stores, Retail Pharmacies, Others), End User (Hospital, Pedi...
$ 3800
Vulvodynia Treatment Comprehensive Study by Application (Hospitals, Clinics, Others), Drugs (Local Anesthetics, Topical Estrogen, Tricyclic Antidepressants, Anticonvulsants, Nerve Blocks, Serotonin-N...
$ 3650
Atomic Emission Spectroscopy Comprehensive Study by Type (Flame Emission Spectroscopy, Plasma Emission Spectroscopy), Application (Foods And Drinks, Pharmaceutical Samples, Environmental Samples, Her...
$ 3800
Wound Management Products Comprehensive Study by Type (Adhesive Dressings, Gauze, Non-Adherent Dressings, Hydrogels, Wound Therapy Devices), Application (Hospitals, Specialty Clinics, Home Healthcare...
$ 3750
Veterinary X-ray Comprehensive Study by Type (Digital X-ray, Analog X-ray  ), Application (Orthopedics and Trauma, Oncology, Dental Applications), Technology (Direct (Capture) Radiography Systems, Co...
$ 3750
Growth Medium Comprehensive Study by Type (Classical Media, Stem Cell Media, Lysogeny Broth, Chemically Defined Media, Specialty Media, Serum-free Media, Others), Application (Cancer Research, Biopha...
$ 3750